Form 4: Orthopediatrics Corp. Director Acquires Shares

Marie C. Infante (Reynolds), a Director at Orthopediatrics Corp., acquired 11,436 shares of common stock on June 9, 2026.

Summary

• Marie C. Infante (Reynolds), a Director at Orthopediatrics Corp. (KIDS), acquired 11,436 shares of common stock on June 9, 2026.
• The acquisition was made at a price of $0, indicating it was likely a grant or award.
• Following this transaction, the reporting person beneficially owns 31,202 shares of common stock directly.
• The filing also notes that the total includes 17,959 shares from restricted stock awards.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard director share acquisition which is typical for insider reporting and does not inherently signal a significant change in the company's financial performance or strategic direction.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 11,436 shares at no cost suggests a form of equity compensation or award.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that director share acquisitions, particularly those that appear to be equity awards, are common in the medical device sector as a means of aligning management and board interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but the nature of the acquisition (no cost) suggests it's part of compensation rather than an open market purchase.

Key Dates

Keywords

Orthopediatrics Corp., KIDS, Form 4, Insider Trading, Director, Common Stock, Equity Award, Beneficial Ownership